1 Interstitial Lung Disease Unit, Royal Brompton Hospital/Imperial College London, London, United Kingdom.
2 F. Hoffmann-La Roche, Basel, Switzerland.
J Manag Care Spec Pharm. 2017 Mar;23(3-b Suppl):S3-S4. doi: 10.18553/jmcp.2017.23.3-b.s3.
Maher has received grants, consulting fees, and speaker fees from GlaxoSmithKline and UCB and grants from Novartis. He has also received consulting fees and speaker fees from AstraZeneca, Bayer, Biogen Idec, Boehringer Ingelheim, Cipla, Lanthio, InterMune International AG (a wholly owned Roche subsidiary since 2014), F. Hoffmann-La Roche, Sanofi-Aventis, and Takeda. Maher is supported by a National Institute for Health Research Clinician Scientist Fellowship (NIHR Ref: CS:-2013-13-017). Dejonckheere is an employee of F. Hoffmann-La Roche. Nathan has received consulting fees from Roche-Genentech and Boehringer Ingelheim. He is also on the speakers bureau for Roche-Genentech and Boehringer Ingelheim and has received research funding from both companies. All authors contributed equally to study concept and design, data collection and analysis, and manuscript preparation.
马赫尔曾从葛兰素史克和优时比公司获得过拨款、咨询费和演讲费，也曾从诺华公司获得过拨款。他还曾从阿斯利康、拜耳、百健艾迪、勃林格殷格翰、西普拉、兰蒂欧、因美纳国际股份有限公司（罗氏全资子公司，2014 年起）、罗氏、赛诺菲-安万特和武田制药收取过咨询费和演讲费。马赫尔得到了英国国家卫生研究院临床研究员奖学金（英国国家卫生研究院参考号：CS-2013-13-017）的支持。德容克海耶是罗氏公司的员工。内森曾从罗氏-基因泰克和勃林格殷格翰收取过咨询费。他还在罗氏-基因泰克和勃林格殷格翰的演讲嘉宾名单上，并从这两家公司获得过研究资金。所有作者对研究概念和设计、数据收集和分析以及手稿准备都做出了同等贡献。
